Displaying 21 - 40 of 402
FTC and DOJ File Comment with the U.S. Copyright Office Supporting Renewal and Expansion of Exemptions Facilitating Consumers’ and Businesses’ Right to Repair Their Own Products
Date
The Federal Trade Commission and the Department of Justice’s Antitrust Division (DOJ) have submitted a comment to the U.S. Copyright Office to advocate for regulations that would facilitate consumers’...
FTC Issues Infant Formula Supply Disruptions Report
Date
Today, the Federal Trade Commission issued a report on market factors relevant to infant formula supply disruptions, which details aspects of the U.S. infant formula market that rendered it vulnerable...
Federal Trade Commission, the Department of Justice and the Department of Health and Human Services Launch Cross-Government Inquiry on Impact of Corporate Greed in Health Care
Date
The Federal Trade Commission, the Department of Justice’s (DOJ) Antitrust Division, and the U.S. Department of Health and Human Services (HHS) jointly launched a cross-government public inquiry into...
FTC, HHS Seek Public Comment on Generic Drug Shortages and Competition Amongst Powerful Middlemen
Date
Today the Federal Trade Commission (FTC) and the U.S. Department of Health and Human Services (HHS) jointly issued a Request for Information to understand how the practices of two types of...
FTC to Host Virtual Workshop on Private Equity in Health Care
Date
The Federal Trade Commission will host a virtual workshop, Private Capital, Public Impact: An FTC Workshop on Private Equity in Health Care, on March 5, 2024, to examine the role of private equity...
FTC Submits Comment on March-In Rights to Promote Efforts to Lower Drug Prices
Date
Today the Federal Trade Commission issued a comment in response to the National Institute of Standards and Technology’s (NIST) request for information on its Draft Interagency Guidance Framework for...
FTC Challenges More Than 100 Patents as Improperly Listed in the FDA’s Orange Book
Date
Today, the Federal Trade Commission (FTC) challenged more than 100 patents held by manufacturers of brand-name asthma inhalers, epinephrine autoinjectors, and other drug products as improperly or...
FTC Issues Policy Statement on Brand Pharmaceutical Manufacturers’ Improper Listing of Patents in the Food and Drug Administration’s ‘Orange Book’
Date
The Federal Trade Commission today issued a policy statement , supported by the U.S. Food and Drug Administration (FDA), warning pharmaceutical companies that make and sell brand-name drugs that they...
FTC Votes to Issue Statement Withdrawing Prior Pharmacy Benefit Manager Advocacy
Date
The Federal Trade Commission voted to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit mangers (PBMs) that no longer reflect current...
Federal Trade Commission Withdraws Health Care Enforcement Policy Statements
Date
The Federal Trade Commission announced today the withdrawal of two antitrust policy statements related to enforcement in health care markets: Statements of Antitrust Enforcement Policy in Health Care...
FTC Announces Tentative Agenda for July 20 Open Commission Meeting
Date
Today, Federal Trade Commission Chair Lina M. Khan announced that an open meeting of the Commission will be held virtually on Thursday, July 20, 2023. The open meeting will commence at 11am ET and...
Displaying 21 - 40 of 402